Àngels Ginés

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Glòria Fernández‐Esparrach · 4 shared papers, 2016–2023 · strength 0.41
   • Paper Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. DOI 10.3389/fmolb.2023.1161893↗
   • Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690↗
   • Paper Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected… DOI 10.1016/j.pan.2017.08.004↗
2. Eva Cristina Vaquero · 4 shared papers, 2016–2023 · strength 0.41
   • Paper Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. DOI 10.3389/fmolb.2023.1161893↗
   • Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690↗
   • Paper Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected… DOI 10.1016/j.pan.2017.08.004↗
3. Joan Maurel · 4 shared papers, 2016–2023 · strength 0.32
   • Paper Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. DOI 10.3389/fmolb.2023.1161893↗
   • Paper Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected… DOI 10.1016/j.pan.2017.08.004↗
   • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
4. Fabio Ausania · 2 shared papers, 2023 · strength 0.30
   • Paper Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. DOI 10.3389/fmolb.2023.1161893↗
   • Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690↗
5. Leire Pedrosa · 1 shared paper, 2023 · strength 0.15
   • Paper Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. DOI 10.3389/fmolb.2023.1161893↗
6. Joan Llach · 1 shared paper, 2023 · strength 0.15
   • Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690↗
7. Leticia Moreira · 1 shared paper, 2023 · strength 0.15
   • Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690↗
8. Luis Sabater-Orti · 2 shared papers, 2016–2018 · strength 0.11
   • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
   • Paper [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma]. DOI 10.1016/j.medcli.2016.07.033↗
9. Marta Martín-Richard · 2 shared papers, 2016–2018 · strength 0.11
   • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
   • Paper [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma]. DOI 10.1016/j.medcli.2016.07.033↗
10. Nadia Alberghina · 1 shared paper, 2017 · strength 0.06
    • Paper Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected… DOI 10.1016/j.pan.2017.08.004↗
11. Laureano Fernández‐Cruz · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
12. Santiago Sánchez-Cabús · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
13. Berta Laquente · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
14. Javier Rodríguez · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
15. Susana Roselló · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
16. Laura Visa · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.